Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
22.66-0.34 (-1.48%)
At close: 04:00PM EDT
22.66 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
106,140
106,140
101,418
112,512
106,011
Depreciation & amortisation
2,362
2,362
3,446
3,476
2,237
Deferred income taxes
-29,493
-29,493
-33,905
4,346
14,089
Stock-based compensation
48,940
48,940
42,442
42,931
33,539
Change in working capital
8,218
8,218
5,539
-466
-5,357
Accounts receivable
-10,066
-10,066
-3,432
-1,427
-6,270
Inventory
1,265
1,265
1,199
3,444
-3,514
Accounts payable
5,778
5,778
4,757
-3,597
3,161
Other working capital
126,900
126,900
119,910
167,423
150,732
Other non-cash items
-
-
1,383
10
1,451
Net cash provided by operating activities
127,039
127,039
120,323
167,892
151,970
Cash flows from investing activities
Investments in property, plant and equipment
-139
-139
-413
-469
-1,238
Purchases of investments
-328,748
-328,748
-355,066
-312,805
-420,114
Sales/maturities of investments
419,793
419,793
241,152
449,400
302,089
Net cash used for investing activities
90,906
90,906
-114,327
136,126
-119,263
Cash flows from financing activities
Common stock repurchased
-145,428
-145,428
0
-295,985
-9,945
Other financing activities
-9,106
-9,106
-21,665
-22,835
-1,067
Net cash used provided by (used for) financing activities
-148,723
-148,723
-17,284
-302,591
12,214
Net change in cash
69,222
69,222
-11,288
1,427
44,921
Cash at beginning of period
66,329
66,329
77,617
76,190
31,269
Cash at end of period
135,551
135,551
66,329
77,617
76,190
Free cash flow
Operating cash flow
127,039
127,039
120,323
167,892
151,970
Capital expenditure
-139
-139
-413
-469
-1,238
Free cash flow
126,900
126,900
119,910
167,423
150,732